184 related articles for article (PubMed ID: 33426064)
1. Overexpression of NNT-AS1 Activates TGF-
Wang Y; Yang L; Dong X; Yang X; Zhang X; Liu Z; Zhao X; Wen T
Biomed Res Int; 2020; 2020():8216541. PubMed ID: 33426064
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
3. The lncRNA
Zhou N; Li S; Wu D; Zhang F; Tang F; Li Y
DNA Cell Biol; 2021 Oct; 40(10):1278-1289. PubMed ID: 34558987
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
[TBL] [Abstract][Full Text] [Related]
5. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
Song W; Zhang J; Xia Q; Sun M
Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
[No Abstract] [Full Text] [Related]
6. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
[TBL] [Abstract][Full Text] [Related]
7. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.
Li S; Huang Y; Huang Y; Fu Y; Tang D; Kang R; Zhou R; Fan XG
J Exp Clin Cancer Res; 2017 Apr; 36(1):51. PubMed ID: 28403886
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
9. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
10. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT/mTOR signaling pathways.
Li J; Zhai DS; Huang Q; Chen HL; Zhang Z; Tan QF
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6091-6104. PubMed ID: 31364110
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt/β-catenin pathway.
Ma YK; Shen TH; Yang XY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7855-7862. PubMed ID: 31599410
[TBL] [Abstract][Full Text] [Related]
14. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
[TBL] [Abstract][Full Text] [Related]
17. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
18. A SOX9-AS1/miR-5590-3p/SOX9 positive feedback loop drives tumor growth and metastasis in hepatocellular carcinoma through the Wnt/β-catenin pathway.
Zhang W; Wu Y; Hou B; Wang Y; Deng D; Fu Z; Xu Z
Mol Oncol; 2019 Oct; 13(10):2194-2210. PubMed ID: 31402556
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.
Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
